SPDR S&P Pharmaceuticals ETF
XPH
XPH
73 hedge funds and large institutions have $117M invested in SPDR S&P Pharmaceuticals ETF in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 15 closing their positions.
Holders
73
Holders Change
+6
Holders Change %
+8.96%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
20
Reduced
17
Closed
15
Calls
$3.33M
Puts
$335K
Net Calls
+$3M
Net Calls Change
-$369K
Top Buyers
Top Sellers
1 |
1
Morgan Stanley
New York
|
$18.9M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$17.6M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$0 |
4 |
BCM
4
Brookstone Capital Management
Wheaton,
Illinois
|
$2.16M |
5 |
5
Goldman Sachs
New York
|
$25.9M |